## CFLT: Confluent, Inc. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 4.9% in lower entry zone (4.0-10.0%), top 4% cross-sectional ranking. Short-term MRS_5 (0.6%) confirms momentum alignment. Outperforming sector by 4.7%. Caution: declining volume (14% of avg), momentum weakening (-5.1% MRS), overbought RSI (77).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($29.07)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### Analyst Activity

**Target Signal:** BULLISH (Raises: 6, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Guggenheim | $0 | $0 | 0% |
| 2025-12-09 | Citigroup | $31 | $26 | +19% |
| 2025-12-09 | DA Davidson | $31 | $29 | +7% |
| 2025-12-09 | Canaccord Genui | $31 | $27 | +15% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Guggenheim | down | Neutral |
| 2025-12-09 | Citigroup | main | Neutral |
| 2025-12-09 | DA Davidson | down | Neutral |
| 2025-12-09 | Canaccord Genui | down | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.00M) |
| Sells | 24 ($12.41M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.2% (+10.5%)
- Blackrock Inc.: 8.0% (-5.1%)
- Point72 Asset Manage: 5.6% (+10.5%)
- Altimeter Capital Ma: 3.7% (-27.5%)
- Champlain Investment: 3.6% (-3.9%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-5.1% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $12M sold (24 transactions in 90 days).
3. Premium valuation (P/E 63x, PEG 2.1x) vulnerable to multiple compression.
4. Overbought RSI (77) with bearish MACD signals exhaustion.

### Catalysts

- Analyst target momentum: 6 raises (avg +12%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.12 elevated, pricing in significant growth expectations. Forward P/E 62.5x stretched relative to 21% growth. Balance sheet: strong liquidity (4.0x). Analyst sentiment positive (6 raises, avg +12%). Insider selling cluster ($12.4M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $10.6B |
| Beta | 0.99 |
| 52W Range | $15.64 - $37.90 |
| Short Interest | 4.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.12 |
| Forward P/E | 62.5 |
| Current P/E | 75.5 |
| YoY Growth | 20.7% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 10.0% to 4.9% (-5.1% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 95th percentile. MRS_5 at 0.6% confirms short-term momentum alignment. AM_20 at 5.1% shows strong absolute momentum above own 20MA. Outperforming sector by 4.7pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 77, risk of mean reversion. Volume at 14% of 20MA suggests lack of conviction. OFD pattern: +SBL (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 4.89% (CS: 96) | Strong |
| RSI_14 | 77.3 | Overbought |
| MACD Histogram | -0.11 | Bearish |
| vs SMA20 | 1.051x | Above |
| vs SMA50 | 1.200x | Above |
| vs SMA200 | 1.320x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $30.13
- **Stop Loss:** $29.07 (3.5% risk)
- **Target:** $31.72 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1037
- **Position Value:** $31,244.81
- **Portfolio %:** 31.24%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-11 (Est: $0.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.10 | $0.13 | +33.6% |
| 2025Q2 | $0.08 | $0.09 | +9.4% |
| 2025Q1 | $0.07 | $0.08 | +18.3% |
| 2024Q4 | $0.06 | $0.09 | +57.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*